282
Participants
Start Date
March 13, 2018
Primary Completion Date
June 20, 2019
Study Completion Date
July 9, 2019
KP415 oral capsule
Once-daily oral dose
Clinical Neuroscience Solutions, Inc., Jacksonville
Meridien Research, Maitland
Clinical Neuroscience Solutions, Inc., Orlando
Innovative Clinical Research, Inc., Lauderhill
Meridien Research, Bradenton
Clinical Neuroscience Solutions, Inc., Memphis
Neuro-Behavioral Clinical Research, Canton
Midwest Clinical Research Center, LLC, Dayton
Capstone Clinical Research, Libertyville
Psychiatric Associates, Overland Park
Woodland International Research, Little Rock
Bayou City Research, Ltd., Houston
Houston Clinical Trials, Houston
FutureSearch Trials, Austin
MCB Clinical Research Centers, Colorado Springs
Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas
Oregon Center for Clinical Investigations, Inc., Portland
Oregon Center for Clinical Investigations, Inc., Salem
Hassman Research Institute, Berlin
Lead Sponsor
Zevra Therapeutics
INDUSTRY